Structure–activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition-Reference-Cited by-同舟云学术

Structure–activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition

Published:2002-08 Issue:12 Volume:38 Page:1661-1670
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Touhey S,O'Connor R,Plunkett S,Maguire A,Clynes M

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Multiple Drug Resistance in Cancer 2— Molecular, Cellular and Clinical Aspects. Cytotechnology;Clynes,1998

2. Cellular models for multiple drug resistance in cancer;Clynes;In Vitro Cell Dev. Biol.,1993

3. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line;Cole;Science,1992

4. A family of drug transporters;Borst;J. Natl. Cancer Inst.,2000

5. Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5, homologues of the multidrug resistance associated protein (MRP1), in human cancer cell lines;Kool;Cancer Res.,1997

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indomethacin Derivatives as Potential Anticancer Agents ‐ Daybreak of New Epoch;ChemistrySelect;2024-08-08

2. LDH-Indomethacin Nanoparticles Antitumoral Action: A Possible Coadjuvant Drug for Cancer Therapy;Molecules;2024-07-17

3. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects;European Journal of Medical Research;2023-09-14

4. Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing;Medical Sciences;2022-02-18

5. A critical review on modulators of Multidrug Resistance Protein 1 in cancer cells;PeerJ;2022-01-05